Development and validation of a nomogram for predicting cefoperazone/sulbactam-induced hypoprothrombinaemia in Hospitalized adult patients.

Bai, Hehe; Li, Huan; Nie, Xiaojing; Yao, Yanqin; Han, Xiaonian; Wang, Jinping; Peng, Lirong

Bai, Hehe; Li, Huan; Nie, Xiaojing; Yao, Yanqin; Han, Xiaonian; Wang, Jinping; Peng, Lirong.

Afiliação

Bai H; Department of Pharmacy, Xi' an Central Hospital, Xi'an, Shaanxi, China.
Li H; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
Nie X; Department of Pharmacy, Xi' an Central Hospital, Xi'an, Shaanxi, China.
Yao Y; Department of Pharmacy, The Third Affiliated Hospital of Xi 'an Medical University, Xi'an, Shaanxi, China.
Han X; Department of Pharmacy, Xi' an Central Hospital, Xi'an, Shaanxi, China.
Wang J; Department of Pharmacy, Xi' an Central Hospital, Xi'an, Shaanxi, China.
Peng L; Department of Pharmacy, Xi' an Central Hospital, Xi'an, Shaanxi, China.

PLoS One ; 18(9): e0291658, 2023.

Article em En | MEDLINE | ID: mdl-37733780

Assuntos

Hipoprotrombinemias; Humanos; Adulto; Cefoperazona/efeitos adversos; Sulbactam/efeitos adversos; Nomogramas; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipoprotrombinemias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google